Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chubb
Deloitte
Accenture
Farmers Insurance
Healthtrust
Julphar
Harvard Business School
Baxter

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021443

« Back to Dashboard

NDA 021443 describes ENJUVIA, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the ENJUVIA profile page.

The generic ingredient in ENJUVIA is estrogens, conjugated synthetic b. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated synthetic b profile page.
Summary for 021443
Tradename:ENJUVIA
Applicant:Teva Branded Pharm
Ingredient:estrogens, conjugated synthetic b
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021443
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443 NDA Physicians Total Care, Inc. 54868-6163 E 54868-6163-0
ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443 NDA Physicians Total Care, Inc. 54868-6163 E 54868-6163-1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.3MG
Approval Date:Dec 20, 2004TE:RLD:No
Patent:➤ Sign UpPatent Expiration:Mar 8, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY, ASSOCIATED WITH MENOPAUSE
Patent:➤ Sign UpPatent Expiration:Mar 8, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Patent:➤ Sign UpPatent Expiration:Feb 12, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY, ASSOCIATED WITH MENOPAUSE

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Citi
Cipla
Healthtrust
Federal Trade Commission
Julphar
Deloitte
Chubb
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.